Form D · Other Investment Fund
GLL Health Sciences Fund LLC
Chicago, IL · CIK 0001690008
Offering snapshot reported Mar 24, 2026 · SEC filing
- Reported sold
- $16.6M Indefinite offering
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $250K Reported outside-investor minimum
- First sale
- Nov 1, 2016 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$22,118,434 → $16,637,354
- Reported investors18 → 17
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 24, 2026 | Amendment | $16,637,354 | -$5,481,080vs Mar 19, 2025 | 17 | SEC filing |
| Mar 19, 2025 | Amendment | $22,118,434 | -$466,749vs Mar 7, 2024 | 18 | SEC filing |
| Mar 7, 2024 | Initial | $22,585,183 | No comparison | 21 | SEC filing |
| Mar 21, 2023 | Initial | $22,272,231 | No comparison | 25 | SEC filing |
| Mar 10, 2022 | Initial | $30,323,741 | No comparison | 28 | SEC filing |
| Mar 8, 2021 | Amendment | $34,316,954 | $7,418,010vs Mar 30, 2020 | 26 | SEC filing |
| Mar 30, 2020 | Amendment | $26,898,944 | $6,656,314vs Mar 27, 2020 | 26 | SEC filing |
| Mar 27, 2020 | Amendment | $20,242,630 | $2,950,000vs Mar 25, 2019 | 26 | SEC filing |
| Mar 25, 2019 | Amendment | $17,292,630 | $0vs Mar 22, 2019 | 25 | SEC filing |
| Mar 22, 2019 | Amendment | $17,292,630 | $1,376,320vs Mar 8, 2018 | 25 | SEC filing |
| Mar 8, 2018 | Amendment | $15,916,310 | $8,263,701vs Mar 9, 2017 | 23 | SEC filing |
| Mar 9, 2017 | Amendment | $7,652,609 | $0vs Mar 8, 2017 | 18 | SEC filing |
| Mar 8, 2017 | Amendment | $7,652,609 | -$1,008,936vs Nov 15, 2016 | 18 | SEC filing |
| Nov 15, 2016 | Initial | $8,661,545 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-506995
As of 12/31/25
Source: Form D, filed Mar 24, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
GLL HEALTH SCIENCES FUND LLC
Investment adviser: GLL INVESTORS, LLC
- Gross asset value
- $16.6M
- Beneficial owners
- 14
- ADV minimum commitment
- $250K
Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- Yes
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
RYAN & JURASKA
PCAOB 3407
Filing source
Form ADV 2084273 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-1442962595
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Stephen Gilboy | Executive, Promoter |
| Jason Gilboy | Executive, Promoter |
| Gll Investors Llc | Promoter |
| Michael Newlander | Executive, Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:Chicago, IL, 60657